Investor meeting March 19, 2024
Isofol invited to an investor meeting where the board and management presented the strategy going forward and the clinical development programme for arfolitixorin. The meeting were held in Gothenburg but could also be followed online. The presentation was mainly held in Swedish and participants had the opportunity to ask questions, both on site and online.
Webcast
https://ir.financialhearings.com/isofol-medical-investor-meeting-2024
Last updated 05-08-2024